AbbVie Inc. (ABBV) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-03-06

Key Insights

Demetris D. Crum, the EVP and Chief HR Officer of AbbVie Inc., disposed of 1,594 shares of the company's common stock on February 27, 2026, at a price of $232.08 per share.
Following this transaction, Crum now directly owns 7,914 shares of AbbVie stock, a decrease from the previous reported ownership.
This insider sale transaction may indicate a potential change in the executive's confidence or outlook regarding the company's performance or future prospects.

Want the newest filings?

This analysis covers the filing from 2026-03-06. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-03-06

David R. Purdue, the SVP and Controller of AbbVie Inc., sold 5,230 shares of common stock on March 4, 2026 at a price of $233.56 per share.
Purdue still holds 2,654 shares of AbbVie stock directly, as well as an additional 543 shares in the AbbVie Savings program.
The insider selling activity may indicate a potential loss of confidence in the company's near-term prospects or a desire to diversify personal holdings.

Other reports for AbbVie Inc.

Current Report Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.